DELTAREX-G GAINS FDA AUTHORIZATION AS ADJUVANT THERAPY FOR EARLY-STAGE TRIPLE NEGATIVE METAPLASTIC BREAST CANCER
PREVENTING RECURRENCE OF TRIPLE NEGATIVE BREAST CANCER WITH TUMOR-TARGETED GENE THERAPY LOS ANGELES, CALIFORNIA, UNITED STATES, June 27, 2021 /EINPresswire.com/ -- The Aveni Foundation (www.avenifoundation.org), and the Cancer Center of Southern …